Anisometropia at Age 5 Years After Unilateral Intraocular Lens Implantation During Infancy in the Infant Aphakia

David Weakley1, George Cotsonis2, M Edward Wilson3

  • 1Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.

Insights

Most infants who received intraocular lens (IOL) implantation for unilateral cataracts developed significant anisometropia by age 5. Glaucoma further increased this refractive difference, highlighting challenges in infant eye care.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Refractive Error

Background:

  • Unilateral congenital cataracts require early intervention, often involving intraocular lens (IOL) implantation.
  • Achieving emmetropia in infants post-IOL implantation is complex due to ongoing eye growth and refractive changes.
  • Anisometropia, a significant difference in refractive error between eyes, is a common concern after pediatric cataract surgery.

Purpose of the Study:

  • To determine the prevalence of anisometropia at age 5 years in infants treated for unilateral cataracts with IOL implantation.
  • To investigate factors influencing anisometropia, specifically the impact of developing glaucoma.

Main Methods:

  • Prospective randomized clinical trial within the Infant Aphakia Treatment Study (IATS).
  • Fifty-seven infants with unilateral cataracts underwent randomized IOL implantation targeting either +8D or +6D postoperative refractive error based on age at surgery (28 to <48 days or 48-210 days, respectively).
  • Anisometropia was assessed at age 5 years; 6 patients were excluded from analysis.

Main Results:

  • The majority of pseudophakic eyes exhibited significant anisometropia by age 5 years, with a median anisometropia of -3.50D (IQR -8.25D to -0.88D).
  • Patients who developed glaucoma in the treated eye showed significantly greater anisometropia (median -8.25D) compared to those without glaucoma (median -2.75D; P=0.005).
  • Refractive errors at age 5 years were -2.25D (IQR -5.13D to +0.88D) in treated eyes and +1.50D (IQR +0.88D to +2.25D) in fellow eyes.

Conclusions:

  • Significant anisometropia is prevalent at age 5 years following unilateral IOL implantation in infants with cataracts.
  • The development of glaucoma in the treated eye is associated with increased anisometropia.
  • Variability in infant eye growth and myopic shift presents ongoing challenges for achieving optimal refractive outcomes with early IOL implantation.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
6.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K